ASEAN: Market for Hormones, Prostaglandins, Thromboxanes And Leukotrienes 2024

Market Size for Hormones, Prostaglandins, Thromboxanes And Leukotrienes in ASEAN

The ASEAN market for hormones, prostaglandins, thromboxanes and leukotrienes stood at $X in 2022, therefore, remained relatively stable against the previous year. Over the period under review, consumption showed a buoyant expansion. Over the period under review, the market hit record highs in 2022 and is likely to see steady growth in years to come.

Production of Hormones, Prostaglandins, Thromboxanes And Leukotrienes in ASEAN

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes production expanded significantly to $X in 2022 estimated in export price. Overall, production posted resilient growth. The pace of growth appeared the most rapid in 2015 when the production volume increased by X%. The level of production peaked at $X in 2020; however, from 2021 to 2022, production failed to regain momentum.

Exports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Exports in ASEAN

In 2022, approx. X tons of hormones, prostaglandins, thromboxanes and leukotrienes were exported in ASEAN; picking up by X% compared with 2021. Over the period under review, exports, however, continue to indicate a perceptible reduction. The most prominent rate of growth was recorded in 2020 with an increase of X%. As a result, the exports attained the peak of X tons. From 2021 to 2022, the growth of the exports remained at a somewhat lower figure.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes exports soared to $X in 2022. Overall, exports, however, showed a deep reduction. The pace of growth was the most pronounced in 2016 when exports increased by X%. Over the period under review, the exports reached the peak figure at $X in 2012; however, from 2013 to 2022, the exports failed to regain momentum.

Exports by Country

Malaysia represented the key exporter of hormones, prostaglandins, thromboxanes and leukotrienes in ASEAN, with the volume of exports amounting to X tons, which was near X% of total exports in 2022. It was distantly followed by Singapore (X tons) and Thailand (X tons), together achieving a X% share of total exports. Indonesia (X tons) took a relatively small share of total exports.

Malaysia was also the fastest-growing in terms of the hormones, prostaglandins, thromboxanes and leukotrienes exports, with a CAGR of X% from 2012 to 2022. At the same time, Indonesia (X%) displayed positive paces of growth. By contrast, Thailand (X%) and Singapore (X%) illustrated a downward trend over the same period. While the share of Malaysia (X p.p.) increased significantly in terms of the total exports from 2012-2022, the share of Singapore (X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Singapore ($X) remains the largest hormones, prostaglandins, thromboxanes and leukotrienes supplier in ASEAN, comprising X% of total exports. The second position in the ranking was held by Malaysia ($X), with a X% share of total exports. It was followed by Indonesia, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value in Singapore totaled X%. In the other countries, the average annual rates were as follows: Malaysia (X% per year) and Indonesia (X% per year).

Export Prices by Country

The export price in ASEAN stood at $X per kg in 2022, surging by X% against the previous year. Over the period under review, the export price, however, faced a abrupt decrease. The most prominent rate of growth was recorded in 2016 when the export price increased by X%. The level of export peaked at $X per kg in 2012; however, from 2013 to 2022, the export prices remained at a lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Singapore ($X per kg), while Thailand ($X per kg) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Indonesia (X%), while the other leaders experienced mixed trends in the export price figures.

Imports of Hormones, Prostaglandins, Thromboxanes And Leukotrienes

Imports in ASEAN

In 2022, supplies from abroad of hormones, prostaglandins, thromboxanes and leukotrienes increased by X% to X tons, rising for the fourth consecutive year after four years of decline. Total imports indicated a resilient increase from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by X% against 2018 indices. The growth pace was the most rapid in 2013 with an increase of X% against the previous year. Over the period under review, imports hit record highs in 2022 and are expected to retain growth in the near future.

In value terms, hormones, prostaglandins, thromboxanes and leukotrienes imports contracted to $X in 2022. In general, imports showed a relatively flat trend pattern. The pace of growth appeared the most rapid in 2014 when imports increased by X% against the previous year. As a result, imports attained the peak of $X. From 2015 to 2022, the growth of imports remained at a lower figure.

Imports by Country

Brunei Darussalam was the main importing country with an import of around X tons, which accounted for X% of total imports. Malaysia (X tons) ranks second in terms of the total imports with a X% share, followed by the Philippines (X%), Thailand (X%) and Indonesia (X%). The following importers - Vietnam (X tons) and Singapore (X tons) - each recorded a X% share of total imports.

Brunei Darussalam was also the fastest-growing in terms of the hormones, prostaglandins, thromboxanes and leukotrienes imports, with a CAGR of X% from 2012 to 2022. At the same time, the Philippines (X%), Vietnam (X%) and Thailand (X%) displayed positive paces of growth. By contrast, Malaysia (X%), Indonesia (X%) and Singapore (X%) illustrated a downward trend over the same period. Brunei Darussalam (X p.p.), the Philippines (X p.p.) and Vietnam (X p.p.) significantly strengthened its position in terms of the total imports, while Singapore, Malaysia and Indonesia saw its share reduced by X%, X% and X% from 2012 to 2022, respectively. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, the largest hormones, prostaglandins, thromboxanes and leukotrienes importing markets in ASEAN were Indonesia ($X), Vietnam ($X) and Singapore ($X), together comprising X% of total imports. Malaysia, Thailand, the Philippines and Brunei Darussalam lagged somewhat behind, together comprising a further X%.

Brunei Darussalam, with a CAGR of X%, recorded the highest rates of growth with regard to the value of imports, in terms of the main importing countries over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The import price in ASEAN stood at $X per ton in 2022, reducing by X% against the previous year. In general, the import price showed a pronounced shrinkage. The pace of growth was the most pronounced in 2014 when the import price increased by X% against the previous year. Over the period under review, import prices attained the peak figure at $X per ton in 2017; however, from 2018 to 2022, import prices failed to regain momentum.

There were significant differences in the average prices amongst the major importing countries. In 2022, amid the top importers, the country with the highest price was Vietnam ($X,556 per ton), while Brunei Darussalam ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Indonesia (X%), while the other leaders experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :